Schrodinger, Inc. (SDGR) stock
SDGRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/3079% above fair value
$30.85−0.67 (-2.13%)
Close on Nov 12, 2026Market cap $2.31BP/E –Yield –
Schrodinger enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Schrodinger's enterprise value was $1.93B on Nov 11, 2026, against $885.12M a year earlier. Over the last 5 years it ranged from $438.85M to $3.23B, with a median of $1.11B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.93B | +112.1% |
| 2025 | Dec 31, 2025 | $908.55M | -10.4% |
| 2024 | Dec 31, 2024 | $1.01B | -52.0% |
| 2023 | Dec 29, 2023 | $2.11B | +148.6% |
| 2022 | Dec 30, 2022 | $849.30M | -45.2% |
| 2021 | Dec 31, 2021 | $1.55B | -59.9% |
| 2020 | Dec 31, 2020 | $3.86B | – |
See a number that looks wrong?